Olga Potapova, Ph.D.
Executive Director (USA)
Marketing and Client Relations
Olga Potapova is an expert in biotechnology, life sciences business development and international alliance management.
Since 2003, Dr. Potapova leads Cureline, a group of companies working in the area of translational medicine research and laboratory services. Previously she worked in the fields of cancer research (NIH and Pfizer/SUGEN), human molecular genetics and genomics, oncology drug R&D and translational medicine.
Olga has advanced degrees in Physics and Biochemistry and received multiple AACR/AFLAC awards, NIH and NATO fellowships.
Dmitry V. Belyaev, M.D.
Executive Director (Russia)
Dmitry Belyaev has participated in the clinical research industry in Eastern Europe since the early 1990s. Dmitry oversees all Cureline activities in Russia and is responsible for protocol reviews and regulatory submissions.
Dmitry has a broad clinical research experience in a number of therapeutic areas, including Psychiatry, Oncology, Pediatrics, Cardiology, and Immunology. Dmitry is an expert in Quality Assurance, GCP/GLP, and regulatory affairs for medicines and medical devices in the Russian Federation. He was also involved in the design and management of preclinical animal studies, and was a Deputy Scientific Director of one of the first biotechnology companies in Russia.
Dmitry Belyaev received an M.D. from the Pavlov Medical Academy (St. Petersburg, Russia), and holds clinical certificates in Emergency Medicine and Psychiatry.
Sumit Seth, MD
Clinical Trials (Russia)
Dr. Seth has over 10 years of experience in running clinical research programs for European and US sponsors in Russia and CEE. Before joining us Dr. Seth was the Managing Director for Russia at a pan-European CRO. Dr. Seth started the Russian affiliate single handedly in 2003 and grew up to 50 employee company in 2010 and managed studies in a wide range of therapeutic area. Even before, in 2001, Dr. Seth co-founded a local Russian CRO which was taken over by a mid-sized US CRO.